Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

74
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
74
Inflammation01:38

Inflammation

53.3K
Overview
53.3K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

134
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
134
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

152
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
152

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing Regional Access to Extracorporeal Cardiopulmonary Resuscitation: A Geographic-Information-System-Based Comparison of Hospital- and Prehospital-Initiated Strategies in Nara Prefecture, Japan.

Healthcare (Basel, Switzerland)·2026
Same author

Impact of early cardiac arrest recognition by emergency medical service dispatchers on out-of-hospital cardiac arrest: a retrospective population-based observational study.

International journal of emergency medicine·2026
Same author

Effects of Protein and Amino Acid Supplementation on Physical Performance in Patients With Chronic Heart Failure　- A Systematic Review and Meta-Analysis.

Circulation reports·2026
Same author

Utility of RECELL for Traumatic Skin Defects: Protocol for a Prospective, Single-Arm Pilot Study.

JMIR research protocols·2026
Same author

Long-term Safety and Efficacy of Bempedoic Acid in Japanese Patients with Hypercholesterolemia: the CLEAR-J LONG.

Journal of atherosclerosis and thrombosis·2025
Same author

Three-Year Outcome of Drug Coated Balloon Angioplasty Following Atherectomy for Severely Calcified Coronary Lesions.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2025

Related Experiment Video

Updated: Jun 21, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.3K

Initial decrease in the lipoprotein(a) level is a novel prognostic biomarker in patients with acute coronary

Yasuhiko Saeki1, Jun Sawaguchi1, Satori Akita1

  • 1Department of Cardiology, Kanazawa Medical University, Uchinada 9200293, Japan.

World Journal of Cardiology
|July 12, 2024
PubMed
Summary

Lipoprotein(a) levels decrease after percutaneous coronary intervention in acute coronary syndrome patients. A larger Lp(a) drop indicates a worse prognosis for major adverse cardiac events.

Keywords:
Acute coronary syndromeLipoprotein (a)Major adverse cardiac eventsPercutaneous coronary interventionPrognosis

More Related Videos

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.3K
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

11.1K

Related Experiment Videos

Last Updated: Jun 21, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.3K
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.3K
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

11.1K

Area of Science:

  • Cardiology
  • Biochemistry
  • Clinical Medicine

Background:

  • Lipoprotein(a) [Lp(a)] is a known risk factor for atherosclerotic cardiovascular diseases.
  • The specific role of Lp(a) in acute coronary syndrome (ACS) requires further clarification.

Purpose of the Study:

  • To test if Lp(a) levels change during the acute phase of ACS.
  • To determine if these changes correlate with subsequent cardiovascular events.

Main Methods:

  • 377 ACS patients undergoing coronary angiography were analyzed.
  • Lp(a) levels were measured before and up to 48 hours after percutaneous coronary intervention (PCI).
  • Major adverse cardiac events (MACE) were tracked for a median of 1000 days.

Main Results:

  • Lp(a) levels significantly decreased 12 hours post-PCI, then rose by 48 hours.
  • The magnitude of Lp(a) decrease correlated with baseline creatinine and Lp(a) levels.
  • A greater Lp(a) decrease was linked to higher MACE rates.

Conclusions:

  • Emergent PCI in ACS patients causes a significant reduction in circulating Lp(a) levels.
  • A pronounced decrease in Lp(a) post-PCI is an independent predictor of adverse cardiovascular outcomes.